Charlotte’s Web Holdings (TSE:CWEB) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Charlotte’s Web Holdings shares promising Phase 1 trial results for AJA001, a botanical drug developed for autism spectrum disorder, showcasing its safety and potential efficacy. The trial leverages a proprietary hemp extract, underscoring the company’s commitment to innovative therapies for underserved conditions.
For further insights into TSE:CWEB stock, check out TipRanks’ Stock Analysis page.
